AAV9-CMV-SaCas9 | SCGE Toolkit

SCGE Consortium Home | About SCGE Toolkit | Contact Us | Citing the Toolkit | License

Summary Projects & Experiments

SCGE ID	14000000048
Name	AAV9-CMV-SaCas9
Description	AAV serotype 9 delivering CMV driven SaCas9
Type	Viral Vector
Subtype	AAV

Source	Asokan Lab

Genome Serotype	AAV2
Capsid Serotype	AAV9
Stock/Catalog/RRID	AAV9-CMV-SaCas9

Annotated Map	pLH9.gb
Titer Method	qPCR

Publication Title
Cross-species evolution of a highly potent AAV variant for therapeutic gene transfer and genome editing. NCBI

This Vector/Format: AAV9-CMV-SaCas9 is being used ...

Project	Initiative	Contact PI
Evolving High Potency AAV Vectors for Neuromuscular Genome Editing Experiments Comparing CRISPR/Cas9 gene editing efficencies between AAV9 and AAVcc47 in Ai9 mice with a 1:1 Cas9 to sgRNA ratio (CMV promoter) and self complementary sgRNA vector. Comparing CRISPR/Cas9 gene editing efficiencies between AAV9 and AAVcc47 in Ai9 mice with a 1:3 Cas9 to sgRNA ratio (CMV promoter) Comparing CRISPR/Cas9 gene editing efficencies between AAV9 and AAVcc47 in Ai9 mice with a 1:1 cas9 to sgRNA ratio (CMV promoter)	Delivery Systems	Aravind Asokan, PhD (Duke University)